Slika omota

NTRK fusions in osteosarcoma are rare and non‐functional events

Abstract Neurotrophic tyrosine receptor kinase (NTRK) fusions are promising molecular targets that have been described in a broad range of malignant tumours. Fusions commonly lead to the expression of chimeric proteins with constitutive tyrosine kinase activation that drives tumorigenesis. Despite a...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Baptiste Ameline (Autor), Karim H Saba (Autor), Michal Kovac (Autor), Linda Magnusson (Autor), Olaf Witt (Autor), Stefan Bielack (Autor), Michaela Nathrath (Autor), Karolin H Nord (Autor), Daniel Baumhoer (Autor)
Format:	Knjiga
Izdano:	Wiley, 2020-04-01T00:00:00Z.
Teme:	article
Online pristup:	Connect to this object online.
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
od: Baptiste Ameline, i dr.
Izdano: (2021)

Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
od: Jeongwan Kang, i dr.
Izdano: (2020)

Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
od: Ben J. Friedman, i dr.
Izdano: (2020)

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population
od: Ruiying Zhao, i dr.
Izdano: (2021)

NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
od: Vasiliki Siozopoulou, i dr.
Izdano: (2022)

Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
od: Mariana Petaccia de Macedo, i dr.
Izdano: (2023)

Review of mifamurtide in the treatment of patients with osteosarcoma
od: Leo Kager, i dr.
Izdano: (2010)

A case of thyroid carcinoma with mucinous features harboring ETV6-NTRK3 fusion: Expanding the morphologic spectrum of NTRK-rearranged thyroid carcinoma
od: Khaled A. Murshed, i dr.
Izdano: (2022)

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
od: Tingting Jiang, i dr.
Izdano: (2021)

Identification of Trim24 as a new NTRK3 fusion partner in lung adenocarcinoma: Diagnostic challenges of a novel fusion
od: Almudena Santón, i dr.
Izdano: (2022)

Pleomorphic xanthoastrocytoma with NTRK fusion presenting as spontaneous intracranial hemorrhage-case report and literature review
od: Yilong Wu, i dr.
Izdano: (2024)

NTRK-fusion associated sarcoma: Identification of two cases with a distinct perineurioma-like pattern
od: Vanessa Young, i dr.
Izdano: (2022)

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
od: Erdel Martin, i dr.
Izdano: (2011)

Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion
od: Olivia G. Beck, i dr.
Izdano: (2023)

KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas
od: Aida Catic, i dr.
Izdano: (2020)

Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing
od: Warren H. Chan, BS, i dr.
Izdano: (2020)

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
od: Liu D, i dr.
Izdano: (2018)

Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma
od: Karim H Saba, i dr.
Izdano: (2020)

MYC amplifications are common events in childhood osteosarcoma
od: Solange De Noon, i dr.
Izdano: (2021)

Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372]
od: Tingting Jiang, i dr.
Izdano: (2022)

Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature
od: Siobhan S. Pattwell, i dr.
Izdano: (2020)

NTRK Gene Expression Analysis in Oral Squamous Cell Carcinoma Mexican Population
od: Lilibeth Stephania Escoto-Vasquez, i dr.
Izdano: (2024)

TMP3-NTRK1 rearranged uterine sarcoma: A case report
od: William Boyle, i dr.
Izdano: (2020)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
od: Yuchun Niu, i dr.
Izdano: (2020)

Osteosarcoma
od: Juan Pablo Zapata, i dr.
Izdano: (2019)

Osteosarcoma
Izdano: (2012)

Educational Case: Primary Osteosarcoma
od: Aldis H. Petriceks BA, i dr.
Izdano: (2019)

Novel Gross Deletion Mutations in NTRK1 Gene Associated With Congenital Insensitivity to Pain With Anhidrosis
od: Lulu Li, i dr.
Izdano: (2021)

Low‐grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw
od: Aya Sasaki, i dr.
Izdano: (2021)

Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease
od: Daniele Marinelli, i dr.
Izdano: (2022)

Osteosarcoma of The Maxilla : A Case Report
od: Mandavi S Garud, i dr.
Izdano: (2005)

Osteosarcoma mandibular
od: Daniel A. Carretero Ancelmo, i dr.
Izdano: (2011)

Osteosarcoma of the Mandible
od: Sunali Khanna, i dr.
Izdano: (2004)

Osteosarcoma of maxilla
od: N M Praveena, i dr.
Izdano: (2012)

Immunotherapy for osteosarcoma
od: Kenichiro Yahiro, i dr.
Izdano: (2021)

Chondroblastic osteosarcoma
od: Neha Bhardwaj, i dr.
Izdano: (2024)

Penile osteosarcoma
od: Daniel Abensur Athanazio, i dr.
Izdano: (2023)

Calcaneal osteosarcoma
od: Mahima Sharma, i dr.
Izdano: (2012)

Osteosarcoma Biology, Behavior and Mechanisms
Izdano: (2017)

Osteosarcoma Diagnosis, Mechanisms, and Translational Developments
Izdano: (2019)